Cite
MLA Citation
D.S. Moeller et al.. “OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial.” Radiotherapy and oncology, vol. 119, n.d., pp. S259–. http://access.bl.uk/ark:/81055/vdc_100035408211.0x000046